Profile
Corporate information
Official name
Bausch+Lomb Incorporated
Registration country
Official name
Bausch+Lomb Incorporated
Registration country
Investment activity status
Active investor
Company type
One of the best-known health-care brands in the world and offers one of the most comprehensive product portfolios in the ophthalmic industry.Funding
Funding rounds
Acquisition USD 8,700,000,000
USD 8,700,000,000 (28 May 2013) at USD 8,700,000,000 valuation.
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Valeant Pharmaceuticals International | USD 8,700,000,000 (USD 8,700,000,000). Initial investment. Led the round. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Valeant Pharmaceuticals International |
Acquisition | |
|
Warburg Pincus LLC Private equity firm |
+1 (212) 878-0600 |
N/A |
Investments
Selected investments
| Company | Country | Notes | ||
|---|---|---|---|---|
|
|
eyeonics Inc |
United States | N/A |